Methylphenidate and Reduced Overweight in Children With ADHDShow others and affiliations
2020 (English)In: Journal of Attention Disorders, ISSN 1087-0547, E-ISSN 1557-1246, Vol. 24, no 2, p. 246-254Article in journal (Refereed) Published
Abstract [en]
OBJECTIVE: The objective of this study was to investigate odds ratios of overweight/obesity in children with ADHD and to compare the change in body mass index (BMI) after initiation of methylphenidate treatment in normal versus overweight/obese children.
METHOD: This population-based study included 724 children (<18 years), of whom 197 were girls. Odds ratios for overweight and obesity were calculated, comparing the study group with a reference group from the same area. After initiation of methylphenidate treatment, changes in BMI were assessed for up to 3 years.
RESULTS: Children with ADHD had an odds ratio of 1.87 (95% confidence interval [CI]: [1.60, 2.19]) for overweight/obesity. A decrease in BMI standard deviation score was identified 1 to 3 years into treatment. The decrease was beneficially greater in overweight/obese as compared with normal weight children-mean ( SD) -0.64 (0.80) versus -0.39 (0.68); p = .001-and greater in girls.
CONCLUSION: Medication with methylphenidate may facilitate favorable weight development in children with ADHD and overweight/obesity.
Place, publisher, year, edition, pages
Sage Publications, 2020. Vol. 24, no 2, p. 246-254
Keywords [en]
ADHD, children, pharmacological treatment, weight
National Category
Psychiatry Public Health, Global Health, Social Medicine and Epidemiology
Identifiers
URN: urn:nbn:se:oru:diva-70006DOI: 10.1177/1087054718808045ISI: 000504933400007PubMedID: 30371133Scopus ID: 2-s2.0-85059504805OAI: oai:DiVA.org:oru-70006DiVA, id: diva2:1261256
2018-11-062018-11-062021-12-15Bibliographically approved